These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22010784)

  • 41. Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease.
    Casey RG; Joyce M; Roche-Nagle G; Chen G; Bouchier-Hayes D
    J Surg Res; 2005 Feb; 123(2):176-81. PubMed ID: 15680375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A defective angiogenesis in chronic kidney disease.
    Futrakul N; Butthep P; Laohareungpanya N; Chaisuriya P; Ratanabanangkoon K
    Ren Fail; 2008; 30(2):215-7. PubMed ID: 18300124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microvascular disease and endothelial dysfunction in chronic kidney diseases: therapeutic implication.
    Futrakul N; Butthep P; Patumraj S; Siriviriyakul P; Futrakul P
    Clin Hemorheol Microcirc; 2006; 34(1-2):265-71. PubMed ID: 16543646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The treatment of hypertensive patients with renal insufficiency--a comparison of the blood pressure management in patients with diabetic nephropathy and patients with hypertensive nephropathy].
    Arima S; Abe K; Kudo K; Tsunoda K; Kohzuki M; Imai Y; Saito T; Sato H; Yokozawa S; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):1001-9. PubMed ID: 1770621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Arterial hypertension and diabetic nephropathy].
    Chaignon M; Guedon J
    J Mal Vasc; 1992; 17(4):311-4. PubMed ID: 1494060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?
    Higgins GC; Coughlan MT
    Br J Pharmacol; 2014 Apr; 171(8):1917-42. PubMed ID: 24720258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of vascular endothelial growth factor in kidney disease.
    Doi K; Noiri E; Fujita T
    Curr Vasc Pharmacol; 2010 Jan; 8(1):122-8. PubMed ID: 19485913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urgent call for reconsideration of chronic kidney disease.
    Futrakul N; Futrakul P
    World J Nephrol; 2012 Dec; 1(6):155-9. PubMed ID: 24175254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comprehensive genomic profiling in diabetic nephropathy reveals the predominance of proinflammatory pathways.
    Kelly KJ; Liu Y; Zhang J; Goswami C; Lin H; Dominguez JH
    Physiol Genomics; 2013 Aug; 45(16):710-9. PubMed ID: 23757392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stem Cell Therapy for Microvascular Injury Associated with Ischemic Nephropathy.
    Textor SC; Abumoawad A; Saad A; Ferguson C; Dietz A
    Cells; 2021 Mar; 10(4):. PubMed ID: 33807289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pathophysiology of diabetic nephropathy: a literature review].
    Meza Letelier CE; San Martín Ojeda CA; Ruiz Provoste JJ; Frugone Zaror CJ
    Medwave; 2017 Jan; 17(1):e6839. PubMed ID: 28112712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tubulointerstitial disease: role of ischemia and microvascular disease.
    Nakagawa T; Kang DH; Ohashi R; Suga S; Herrera-Acosta J; Rodriguez-Iturbe B; Johnson RJ
    Curr Opin Nephrol Hypertens; 2003 May; 12(3):233-41. PubMed ID: 12698060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative Micro-Computed Tomography Imaging of Vascular Dysfunction in Progressive Kidney Diseases.
    Ehling J; Bábíčková J; Gremse F; Klinkhammer BM; Baetke S; Knuechel R; Kiessling F; Floege J; Lammers T; Boor P
    J Am Soc Nephrol; 2016 Feb; 27(2):520-32. PubMed ID: 26195818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vascular response to vasodilator treatment in microalbuminuric diabetic kidney disease.
    Futrakul N; Futrakul P
    World J Nephrol; 2013 Nov; 2(4):125-8. PubMed ID: 24255895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The role of endoplasmic reticulum stress in the pregression of kidney disease].
    Liu J; He YN
    Sheng Li Ke Xue Jin Zhan; 2010 Dec; 41(6):439-42. PubMed ID: 21416962
    [No Abstract]   [Full Text] [Related]  

  • 56. Role of the microvascular endothelium in progressive renal disease.
    Kang DH; Kanellis J; Hugo C; Truong L; Anderson S; Kerjaschki D; Schreiner GF; Johnson RJ
    J Am Soc Nephrol; 2002 Mar; 13(3):806-816. PubMed ID: 11856789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renovascular disease, microcirculation, and the progression of renal injury: role of angiogenesis.
    Chade AR
    Am J Physiol Regul Integr Comp Physiol; 2011 Apr; 300(4):R783-90. PubMed ID: 21307362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strategies to prevent progression of renal disease.
    Hall PM
    Cleve Clin J Med; 2001 Feb; 68(2):143-4, 146, 149-51, 152. PubMed ID: 11220456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin.
    Kanbay M; Sánchez-Lozada LG; Franco M; Madero M; Solak Y; Rodriguez-Iturbe B; Covic A; Johnson RJ
    Nephrol Dial Transplant; 2011 Feb; 26(2):430-7. PubMed ID: 20935013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal vascular structure and rarefaction.
    Chade AR
    Compr Physiol; 2013 Apr; 3(2):817-31. PubMed ID: 23720331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.